W. Jonat

16.4k citations
298 papers · 9.8k indexed · 3 hit papers · h-index 48

W. Jonat

283 papers receiving 9.4k citations

Hit Papers

Phase II Randomized Study of Neoadjuvant Everolimus Plus ...5042005202620122019200400600

Peers

W. Jonat
Comparison fields: 5 of 155
  • Cancer Research 3.7k
  • Oncology 4.7k
  • Genetics 3.3k
  • Reproductive Medicine 960
  • Obstetrics and Gynecology 693
Replace Lynn C. Hartmann with:
Lynn C. Hartmann United States
Christian Marth Austria
R. Kreienberg Germany
Patrice Watson United States
Peggy L. Porter United States
J. Michael Dixon United Kingdom
Judith R. Kroep Netherlands
Suzette Delaloge France
Stephen B. Gruber United States
Marianna Zahurak United States
W. Jonat relative to Lynn C. Hartmann United States Lynn C. Hartmann's profile →
Citations per field
00.5×1.5×1.9×
Lynn C. Hartmann · 1×
Citations per year

Countries citing papers authored by W. Jonat

Since Specialization
Citations

This map shows the geographic impact of W. Jonat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jonat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jonat more than expected).

Fields of papers citing papers by W. Jonat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Jonat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jonat. The network helps show where W. Jonat may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W. Jonat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Jonat Line = papers co-authored together W. Jonat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201414
2 20136
3 201369
4 20133
5 201244
6 201271
7 20126
8 201055
9 200920
10 200741
11 200714
12 20041
13
Phase Ii study to define safety and efficacy of exemestane as preoperative therapy for postmenopausal patients with primary breast cancer -final results of the German Neoadjuvant Aromasin Initiative (genari)
200317
14 200367
15 2003202
16
Updated survival results from the Zebra trial.
20022
17 199821
18 1996207
19
Hormone-dependent tumors ; basic research and clinical studies
19951
20
[Bilateral carcinoma of the breast after radiotherapy and chemotherapy for Hodgkin's disease (author's transl)].
19781

About W. Jonat

W. Jonat is a scholar working on Cancer Research, Reproductive Medicine and Oncology, having authored 298 papers that have together received 9.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (73 papers), Breast Cancer Treatment Studies (72 papers), Cancer Treatment and Pharmacology (38 papers), HER2/EGFR in Cancer Research (31 papers), Advanced Breast Cancer Therapies (22 papers), Ovarian cancer diagnosis and treatment (20 papers), Endometriosis Research and Treatment (19 papers) and Prenatal Screening and Diagnostics (18 papers). The work is most often cited by research in Cancer Research (3.7k citations), Oncology (4.7k citations) and Genetics (3.3k citations). W. Jonat has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include W. Eiermann, Manfred Kaufmann, Christoph Mundhenke, Anthony Howell, Nicolaì Maass, Michael Gnant, Carl Blomqvist, Gϋnter von Minckwitz, Liselotte Mettler and İbrahim Alkatout. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Archives of Gynecology and Obstetrics, Journal of Cancer Research and Clinical Oncology and Fertility and Sterility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026